Item 5. MARKET FOR THE REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER

4K characters. Original on sec.gov · Markdown

Item 5. MARKET FOR THE REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER

MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

The Company’s common stock is listed on the NASDAQ stock exchange under the symbol “TECH”. Prior period results have been adjusted to reflect the four-for-one stock split effected in the form of a stock dividend on November 29, 2022. See Note 1 for details.

Holders of Common Stock and Dividends Paid

As of August 12, 2025, there were over 170,000 beneficial shareholders of the Company’s common stock and over 110 shareholders of record. The Company paid annual cash dividends totaling $50.4 million, $50.4 million, and $50.3 million in fiscal 2025, 2024, and 2023, respectively. The Board of Directors periodically considers the payment of cash dividends, and there is no guarantee that the Company will pay comparable cash dividends, or any cash dividends, in the future.

On August 31, 2022, the Company entered into an amended and restated Credit Agreement that provides for a revolving credit facility of $1 billion, which can be increased by an additional $400 million subject to certain conditions. The credit facility is governed by a Credit Agreement dated August 31, 2022 and matures on August 31, 2027. The Credit Agreement that governs the revolving line of credit contains customary events of default and would prohibit payment of dividends to Company shareholders in the event of a default thereunder.

Issuer Purchases of Equity Securities

The Company’s repurchase plan approved by the Board on February 2, 2022, granted management the discretion to mitigate the dilutive effect of stock option exercises. The plan authorized the Company to purchase up to $400 million in stock. Additionally, the Board approved a new share repurchase plan on April 30, 2025, to replace the previous share repurchase plan, that authorizes the Company to purchase up to $500 million of the Company’s stock. The table below sets forth certain information regarding our purchases of common stock in open market transactions during fiscal 2025.

​​​​​​​​​​​
Period​Total Number of Shares Purchased​​Average Price Paid per Share​Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs​​Maximum Dollar Amount of Shares that May Yet Be Purchased Under the Plans or Programs
July 1 - July 31, 2024​—​$—​—​$180,739,094
August 1 - August 31, 2024​—​​—​—​​180,739,094
September 1 - September 30, 2024​—​​—​—​​180,739,094
July 1 - September 30, 2024​—​​—​—​​​
October 1 - 31, 2024​—​​—​—​​180,739,094
November 1 - 30, 20241,118,492​​67.62​1,118,492​​105,110,738
December 1 - 31, 2024​—​​—​—​​105,110,738
October 1 - December 31, 2024​1,118,492​​67.62​1,118,492​​​
January 1 - 31, 2025​—​​—​—​​105,110,738
February 1 - 29, 20251,488,563​​67.21​1,488,563​​5,066,126
March 1 - 31, 2025​—​​—​—​​5,066,126
January 1 - March 31, 2025​1,488,563​​67.21​1,488,563​​​
April 1 - 30, 2025​—​​—​—​​505,066,126
May 1 - 31, 2025​1,943,140​​51.49​1,943,140​​405,007,867
June 1 - 30, 2025​—​​—​—​​405,007,867
April 1 - June 30, 2025​1,943,140​​51.49​1,943,140​​​
July 1, 2024 - June 30, 2025​4,550,195​​60.60​4,550,195​​​

​

​

Stock Performance Graph

The following chart compares the cumulative total shareholder return on the Company’s common stock with the S&P 500 Index and the S&P 500 Life Sciences Tools and Services Index. The comparison assumes $100 was invested on the last trading day before July 1, 2019 in the Company’s common stock and in each of the foregoing indices and assumes reinvestment of dividends. The Company became part of the S&P 500 Index during fiscal 2022.

​

Graphic

​

​

Previous: Item 4. MINE SAFETY DISCLOSURES · Next: Item 6. SELECTED FINANCIAL DATA